Adrenal Cortical Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-02-18
Clinical Trial Update: Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer [Phase 2]
A Phase 2 clinical trial evaluating cabozantinib in combination with pembrolizumab for locally advanced, metastatic, or unresectable adrenal…